Myoma Clinical Trial - The Effect of Intramyometrial Injection of

Status Recruiting

Clinical Trial Summary

For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.

Clinical Trial Description

This study is a prospective, comparative, double-blinded randomized placebo-controlled trial and multi-center study that will be conducted at Wael ElBanna Clinic and the NRC site. The study participants' relevant medical records will be collected and reviewed after obtaining informed consent for the participants. Data will be pooled and presented in aggregate, without the identification of individual subjects. The study materials that will be used will include blood tests and ultrasound. The study will involve three study arms: - Arm 1: intramyometrial Terlipressin injection in women undergoing open myomectomy procedure without using haemostatic tourniquets - Arm 2: intramyometrial Carbetocin injection in women undergoing open myomectomy procedure without using haemostatic tourniquets - Arm 3: intramyometrial saline injection in women undergoing open myomectomy procedure without using haemostatic tourniquets Subjects who meet diagnostic requirements as listed in the inclusion and exclusion criteria will be included in the study. Women will be randomized to one of the three arms using a computergenerated randomization table with a 1:1:1 group allocation ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05266534
Study type	Interventional
Source	Wael Elbanna Clinic
Contact	Wael El Banna
Phone	01227760402
Email	waelelbanna@drwaelelbanna.com
Status	Recruiting
Phase	N/A
Start date	December 30, 2021
Completion date	December 30, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00528177` - Morphine vs. Oxycodone for Postoperative Pain Management	Phase 4
Completed	`NCT05925153` - Vision Screening Study for College Students at Nankai University
Completed	`NCT02737553` - Laparoscopic Enclosed Morcellation; Electromechanic Morcellation vs Vaginal Removal	N/A
Completed	`NCT00891657` - Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy	N/A
Completed	`NCT03972917` - Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy
Completed	`NCT02747550` - Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy	N/A
Completed	`NCT00898170` - Effect of Myoma Removal on Blood Pressure and Erythropoetin Level	N/A
Withdrawn	`NCT02377492` - Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy	N/A
Recruiting	`NCT05806307` - Methods Decreasing Bleeding in Open Myomectomy	Phase 4
Recruiting	`NCT00351494` - Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization	N/A
Completed	`NCT00562471` - Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation	Phase 1/Phase 2
Recruiting	`NCT01564602` - To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy	N/A
Completed	`NCT01032213` - Effect of Magnesium Sulphate on Coagulation	N/A
Completed	`NCT03427671` - OCL 500 Treatment of Women With Symptomatic Uterine Fibroids	N/A
Not yet recruiting	`NCT04694677` - Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.	N/A
Completed	`NCT04983719` - Transcervical Myoma Biopsy Video
Recruiting	`NCT05170230` - The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations	N/A
Recruiting	`NCT05683041` - Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy	N/A
Recruiting	`NCT05242783` - The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:	N/A
Completed	`NCT02853695` - Implementation of Hysteroscopy in Flanders and the Netherlands

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets — myomectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms